MedXtractor’s Reference Database Sets the Stage for SHAMAN & YMI
Ryan Allway
July 13th, 2021
App, Exclusive, Psychedelics, Top Story
Artificial intelligence is already transforming many parts of our everyday lives. For example, Netflix recommends movies we’d enjoy, Facebook identifies friends in photos, and Alexa understands voice commands. Yet, despite these recent advances, most experts agree that AI is only starting to scratch the surface of what’s possible.
According to Grand View Research, the global artificial intelligence market will grow at a 40.2% compound annual growth rate between 2021 and 2028, driven by continued research and innovation by tech giants. From self-driving vehicles to life-saving therapeutics, AI is becoming integral to every apparatus and program.
MedXtractor Corp.’s (CSE: MXT) (OTC: MXTTF) SHAMAN division is applying machine learning to predict potential benefits associated with the use of psychedelic drugs. At the same time, the company’s YMI division is developing consumer mHealth applications to complement smartwatches, DNA test kits, and other mHealth equipment.
Let’s look at the company’s recent progress in building out its reference database and how that translates to near- and long-term opportunities.
Building a Reference Database
Data is the foundation for all artificial intelligence, from machine learning to deep learning algorithms. In fact, building these databases is often one of the most challenging parts of artificial intelligence deployments. It takes a lot of time and effort to gather a large amount of data, fill in missing values, remove duplicates, and prepare it for analysis.
MedXtractor has already collected an estimated 600 fully completed reference records and aims to reach 1000 reference records by the end of September. These records will serve as inputs for machine learning algorithms that aim to diagnose specific mental illnesses and predict their responsiveness to emerging psychedelic treatments.
The company also aims to leverage the very same data for mHealth. In a recent press release, the company said it has reason to believe that there may be causal relationships that influence mental and physical illness development. The company believes that these relationships could show how lifestyle changes might impact future health conditions.
Click here to receive an investor presentation and corporate updates
Near- & Long-term Opportunities
MedXtractor anticipates that SHAMAN and YMI will generate revenue in late 2021. At the same time, the company has been developing these technologies on a tight budget to minimize shareholder dilution and maximize profitability. The large markets for both artificial intelligence and mHealth could mean significant potential gains for investors.
Investors may want to keep a close eye on the stock over the coming quarters as it draws closer to commercialization. With existing reference data in place, the company has surpassed some of the most challenging milestones associated with artificial intelligence. The second half of the year will focus on applying the actual machine learning algorithms.
Over the long term, the company could use similar data collection strategies and algorithms to move into other vertical or horizontal markets. Artificial intelligence has the potential to transform much more than just mental health, creating an opportunity to enter into more multi-billion-dollar markets with a proven technology platform.
Click here to receive an investor presentation and corporate updates
Disclaimer
The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
First Foods Group, Inc. provides management services and funding options for emerging food brands and menu concepts, including a hemp-based chocolate line.
Flora is building a connected, design-led collective, of plant-based wellness and lifestyle brands, that delivers the most compelling customer experiences in the world, one community at a time.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
